Education
About Us
Working with TipRanks
Follow Us
Marshall S. Stanton Insider Profile
4 Followers
Marshall S. Stanton, SVP, Clinical & MD Affair at Artivion, holds 41.92K shares in Artivion (Ticker: AORT). Most recently, Marshall S. Stanton Sold 3,682 shares of Artivion on Feb 25, 2026 for an estimated value of $135.99K.
Marshall S. Stanton Artivion (AORT)SVP, Clinical & MD Affair
Artivion (AORT)
SVP, Clinical & MD Affair
Ranked #92,810 out of 106,131 Corporate Insiders
Profitable Transactions
5 out of 15 Profitable Transactions
Average Return
-17.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Marshall S. Stanton's holdings
Insider Roles
SVP, Clinical & MD Affair
Roles that Marshall S. Stanton holds in companies
Most Profitable Insider Trade
The most profitable trade made by Marshall S. Stanton
Marshall S. Stanton's Trading History
List of latest transactions for each holding click on a transaction to see Marshall S. Stanton's performance on stock
You May Also Like
Marshall S. Stanton insider profile FAQ
What is the percentage of profitable transactions made by Marshall S. Stanton?
The percentage of profitable transactions made by Marshall S. Stanton is 33%.
What is the average return per transaction made by Marshall S. Stanton?
The average return per transaction made by Marshall S. Stanton is -17.70%.
What stocks does Marshall S. Stanton hold?
Marshall S. Stanton holds: AORT stocks.
What was Marshall S. Stanton’s latest transaction?
Marshall S. Stanton latest transaction was an Informative Sell of $135.99K.
What was Marshall S. Stanton's most profitable transaction?
Marshall S. Stanton’s most profitable transaction was an Informative Sell of AORT stock on November 12, 2025. The return on the trade was 19.10%.
What is Marshall S. Stanton's role in Artivion?
Marshall S. Stanton's role in Artivion is SVP, Clinical & MD Affair.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.